Galena Biopharma Announces Notice of Allowance of U.S. Patent for NeuVax™ (nelipepimut-S)
SAN RAMON, Calif., Feb. 08, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology therapeutics that address major unmet medical needs, today …